A Novel Germline CDKN1B Mutation Causing Multiple Endocrine Tumors
Author Information
Author(s): Molatore Sara, Marinoni Ilaria, Lee Misu, Pulz Elke, Ambrosio Maria Rosaria, Uberti Ettore C degli, Zatelli Maria Chiara, Pellegata Natalia S
Primary Institution: Institute of Pathology, Helmholtz Zentrum München
Hypothesis
The study aims to identify new CDKN1B mutations and functionally characterize them in vitro.
Conclusion
The study identified a novel germline mutation in CDKN1B associated with multiple endocrine tumors and characterized its functional implications.
Supporting Evidence
- A novel germline missense variant in CDKN1B was found in a patient with multiple endocrine tumors.
- Functional assays showed that the identified mutations impair the protein's ability to bind to Cdk2 and inhibit cell growth.
- The study extends previous findings of CDKN1B mutations in patients with MEN1-related states.
Takeaway
Scientists found a new mutation in a gene that can cause tumors in people, and they studied how this mutation affects the gene's function.
Methodology
The study screened 27 patients for CDKN1B mutations and performed functional assays on identified mutations.
Limitations
The phenotypic features associated with MEN4 are still undefined due to the small number of mutation-bearing patients reported.
Participant Demographics
The study involved 27 Italian patients with a MEN1-like phenotype, including a 79-year-old Caucasian female.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website